SERAPHINE GROUP PLC

Report Publication Announcement • Jul 28, 2022

National Storage Mechanism | Additional information

RNS Number : 9989T

Seraphine Group PLC

28 July 2022

For immediate release                                                                                                                 28 July 2022

Seraphine Group plc

("Seraphine" or the "Group")

Notice of Results

Seraphine (LON:BUMP), the international digitally-led maternity and nursing wear brand, will report its Final Results for the 12 months ended 3 April 2022 on Monday 1 August 2022.

-Ends-

Enquiries

For further information, please contact:

Seraphine Group	via Buchanan
David N Williams, CEO
Lee Williams, CFO
Buchanan Communications	+44 (0)20 7466 5000 / Seraphine@buchanan.uk.com
Helen Tarbet	+44 (0)7872 604 453
Simon Compton	+44 (0)7979 497 324
Kim Looringh van Beeck	+44 (0)7477 967 446

About Seraphine

Seraphine is an international digitally-led maternity and nursing wear brand with a diverse range of innovative maternity and nursing products serving an under-competed global market.

Seraphine was founded in 2002 with the vision of creating desirable clothes which women would want to wear even if they were not pregnant, and this ethos remains true to this day. The Group has over 18 years' experience designing and developing maternity and nursing wear for women from first trimester to post-partum and nursing products.

The Group has achieved global brand recognition through its rapidly growing digital platform, which in the year to 4 April 2021, contributed to approximately 89% of revenue. The Group currently exports products to customers in over 120 countries globally, with the Group's largest markets being Europe, North America and the UK.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NOREANXXAANAEFA